{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:03:40Z","timestamp":1793325820193,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":2242,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1093\/annonc\/mdt345","type":"journal-article","created":{"date-parts":[[2013,9,3]],"date-time":"2013-09-03T00:39:49Z","timestamp":1378168789000},"page":"vi39-vi50","source":"Crossref","is-referenced-by-count":311,"special_numbering":"S6","title":["Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up"],"prefix":"10.1016","volume":"24","author":[{"given":"M.J.","family":"Seckl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.J.","family":"Sebire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Golfier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Massuger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdt345_bb0010","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(10)60280-2","article-title":"Gestational trophoblastic disease","volume":"376","author":"Seckl","year":"2010","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdt345_bb0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0140-6736(09)60618-8","article-title":"Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study","volume":"374","author":"Schmid","year":"2009","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdt345_bb0020","first-page":"629","article-title":"Changes of clinical features in hydatidiform mole: analysis of 113 cases","volume":"53","author":"Hou","year":"2008","journal-title":"J Reprod Med"},{"key":"10.1093\/annonc\/mdt345_bb0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/uog.3880","article-title":"Histomorphometric features of hydatidiform moles in early pregnancy: relationship to detectability by ultrasound examination","volume":"29","author":"Fowler","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1093\/annonc\/mdt345_bb0030","series-title":"Green-top Guideline","article-title":"The management of early pregnancy loss","author":"Hinshaw","year":"2006"},{"key":"10.1093\/annonc\/mdt345_bb0035","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(04)16898-0","article-title":"Routine terminations of pregnancy-should we screen for gestational trophoblastic neoplasia","volume":"364","author":"Seckl","year":"2004","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdt345_bb0040","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0140-6736(11)61751-0","article-title":"What a difference an egg makes","volume":"378","author":"Fisher","year":"2011","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdt345_bb0045","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0140-6736(02)09085-2","article-title":"Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin","volume":"359","author":"Sebire","year":"2002","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdt345_bb0050","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ygyno.2007.07.081","article-title":"The impact of molecular genetic diagnosis on the management of women with hCG-producing malignancies","volume":"107","author":"Fisher","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdt345_bb0055","first-page":"236","article-title":"Immunohistochemical staining for diagnosis and prognostic assessment of hydatidiform moles: current evidence and future directions","volume":"55","author":"Sebire","year":"2010","journal-title":"J Reprod Med"},{"key":"10.1093\/annonc\/mdt345_bb0060","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.placenta.2012.11.005","article-title":"Histopathological features of biparental complete hydatidiform moles in women with NLRP7 mutations","volume":"34","author":"Sebire","year":"2013","journal-title":"Placenta"},{"key":"10.1093\/annonc\/mdt345_bb0065","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/00000478-199811000-00010","article-title":"Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma","volume":"22","author":"Shih","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdt345_bb0070","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1471-0528.2007.01320.x","article-title":"Shortened duration of human chorionic gonadotrophin surveillance following complete or partial hydatidiform mole: evidence for revised protocol of a UK regional trophoblastic disease unit","volume":"114","author":"Sebire","year":"2007","journal-title":"BJOG"},{"key":"10.1093\/annonc\/mdt345_bb0075","first-page":"445","article-title":"Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report","volume":"47","author":"Kohorn","year":"2002","journal-title":"J Reprod Med"},{"key":"10.1093\/annonc\/mdt345_bb0080","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0140-6736(11)61265-8","article-title":"Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study","volume":"379","author":"Agarwal","year":"2012","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdt345_bb0085","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/bjc.2012.65","article-title":"Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia","volume":"106","author":"Agarwal","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdt345_bb0090","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ygyno.2008.09.005","article-title":"Current management of gestational trophoblastic diseases","volume":"112","author":"Berkowitz","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdt345_bb0095","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2008.10.003","article-title":"Does chest CT matter in the staging of GTN?","volume":"112","author":"Darby","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdt345_bb0100","doi-asserted-by":"crossref","unstructured":"FIGO Oncology Committee. FIGO staging for gestational trophoblastic neoplasia 2000. International Journal of Gynecology & Obstetrics 77:285-287.","DOI":"10.1016\/S0020-7292(02)00063-2"},{"key":"10.1093\/annonc\/mdt345_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007102.pub2","article-title":"First line chemotherapy in low risk gestational trophoblastic neoplasia","volume":"1","author":"Alazzam","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1093\/annonc\/mdt345_bb0110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/gyno.2001.6533","article-title":"Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance?","volume":"85","author":"Kohorn","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdt345_bb0115","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1200\/JCO.2010.30.4386","article-title":"Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study","volume":"29","author":"Osborne","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt345_bb0120","first-page":"283","article-title":"Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia","volume":"57","author":"Lurain","year":"2012","journal-title":"J Reprod Med"},{"key":"10.1093\/annonc\/mdt345_bb0125","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1200\/JCO.2002.07.166","article-title":"Low risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid, 1992 to 2000","volume":"20","author":"McNeish","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt345_bb0130","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/bjc.2012.462","article-title":"Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000\u20132009","volume":"107","author":"Sita-Lumsden","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdt345_bb0135","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ygyno.2012.03.003","article-title":"Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia","volume":"125","author":"Lybol","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdt345_bb0140","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/sj.bjc.6605529","article-title":"The management and outcome of women with post-hydatidiform mole \u2018low-risk\u2019 gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(-1)","volume":"102","author":"McGrath","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdt345_bb0145","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1200\/JCO.2005.03.3043","article-title":"Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease","volume":"24","author":"van Trommel","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt345_bb0150","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/bjc.2013.123","article-title":"Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements","volume":"108","author":"You","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdt345_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005196.pub3","article-title":"Combination chemotherapy for high-risk gestational trophoblastic tumour","volume":"2","author":"Deng","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdt345_bb0160","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S0020-7292(98)80010-6","article-title":"Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT\u201425 years experiences of KRI-TRD","volume":"60","author":"Kim","year":"1998","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1093\/annonc\/mdt345_bb0165","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.1997.15.7.2636","article-title":"EMA\/CO for high-risk gestational trophoblastic tumours: results from a cohort of 272 patients","volume":"15","author":"Bower","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt345_bb0170","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/ijgc-00009577-200605000-00074","article-title":"Results with EMA\/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia","volume":"16","author":"Turan","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1093\/annonc\/mdt345_bb0175","first-page":"465","article-title":"Management of brain metastases in patients with high-risk gestational trophoblastic tumors","volume":"47","author":"Newlands","year":"2002","journal-title":"J Reprod Med"},{"key":"10.1093\/annonc\/mdt345_bb0180","first-page":"262","article-title":"Survival of women with gestational trophoblastic neoplasia and liver metastases: is it improving?","volume":"57","author":"Ahamed","year":"2012","journal-title":"J Reprod Med"},{"key":"10.1093\/annonc\/mdt345_bb0185","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1200\/JCO.2012.43.1817","article-title":"EMA\/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis","volume":"31","author":"Alifrangis","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt345_bb0190","series-title":"Gestational Trophoblastic Disease,","first-page":"335","article-title":"Investigation and treatment of patients with persistent gestational trophoblastic disease and gestational trophoblastic tumours\/neoplasia in the United Kingdom","author":"Seckl","year":"2009"},{"key":"10.1093\/annonc\/mdt345_bb0195","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1093\/annonc\/mds199","article-title":"Human chorionic gonadotropin (hCG) regression normograms for patients with high-risk gestational trophoblastic neoplasia treated with EMA\/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy","volume":"23","author":"Lybol","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdt345_bb0200","first-page":"879","article-title":"Value of whole body 18FDG-PET to identify the active site of gestational trophoblastic neoplasia","volume":"51","author":"Dhillon","year":"2006","journal-title":"J Reprod Med"},{"key":"10.1093\/annonc\/mdt345_bb0205","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ygyno.2005.02.004","article-title":"Secondary chemotherapy for high-risk gestational trophoblastic neoplasia","volume":"97","author":"Lurain","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdt345_bb0210","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1200\/JCO.2000.18.4.854","volume":"18","author":"Newlands","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt345_bb0215","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/gyno.1996.0110","article-title":"Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases","volume":"61","author":"Jones","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdt345_bb0220","first-page":"655","article-title":"Successful salvage of relapsed high-risk gestational trophoblastic neoplasia patients using a novel paclitaxel-containing doublet","volume":"49","author":"Osborne","year":"2004","journal-title":"J Reprod Med"},{"key":"10.1093\/annonc\/mdt345_bb0225","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00001813-199607000-00001","article-title":"Remission of refractory gestational trophoblastic disease with high-dose paclitaxel","volume":"7","author":"Termrungruanglert","year":"1996","journal-title":"Anticancer Drugs"},{"key":"10.1093\/annonc\/mdt345_bb0230","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/annonc\/mdn181","article-title":"Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel\/cisplatin alternating with paclitaxel\/etoposide (TP\/TE)","volume":"19","author":"Wang","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdt345_bb0235","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1471-0528.2004.00065x.x","article-title":"Gestational choriocarcinoma: an unusual presentation with response to gemcitabine and surgery","volume":"111","author":"Pandian","year":"2004","journal-title":"BJOG"},{"key":"10.1093\/annonc\/mdt345_bb0240","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ygyno.2007.04.002","article-title":"Successful salvage of a relapsed high risk gestational trophoblastic neoplasia patient using capecitabine","volume":"106","author":"Bianconi","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdt345_bb0245","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/sj.bjc.6602771","article-title":"High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia","volume":"93","author":"El-Helw","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdt345_bb0250","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0140-6736(05)67143-7","article-title":"Placental site trophoblastic tumour arising from a partial hydatidiform mole","volume":"366","author":"Palmieri","year":"2005","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdt345_bb0255","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ygyno.2005.12.046","article-title":"Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdt345_bb0260","first-page":"643","article-title":"Human chorionic gonadotropin free beta-subunit measurement as a marker of placental site trophoblastic tumors","volume":"53","author":"Harvey","year":"2008","journal-title":"J Reprod Med"},{"key":"10.1093\/annonc\/mdt345_bb0265","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S1470-2045(07)70243-7","article-title":"Fertility-sparing partial hysterectomy for placental-site trophoblastic tumour","volume":"8","author":"Pfeffer","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdt345_bb0270","unstructured":"The ISSTD global Placental Site Trophoblastic Tumour database. International Society of the Study of Trophoblastic Diseases. https:\/\/pstt.shef.ac.uk."},{"key":"10.1093\/annonc\/mdt345_bb0275","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1200\/JCO.1996.14.10.2769","article-title":"Combination but not single agent methotrexate chemotherapy for gestational trophoblastic tumours increases the incidence of second tumours","volume":"14","author":"Rustin","year":"1996","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419315650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419315650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/24\/suppl_6\/vi39\/6677684\/mdt345.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T18:07:16Z","timestamp":1635790036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419315650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":54,"alternative-id":["S0923753419315650"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdt345","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}